Ferric Carboxymaltose Receives US FDA Approval for the Treatment of Iron Deficiency Anemia
On July 25, 2013, American Regent Inc., a subsidiary of Luitpold Pharmaceuticals Inc., announced that Injectafer® (ferric carboxymaltose injection) has received U.S. Food and Drug... Read More
